Stereotaxis Q2 revenue $6.2M, down 32% YoY; net loss $5.2M; cash $35.1M

Stereotaxis, Inc.

2022-Q2 EPS reported -$0.13 revenue$13,189,000

Revenue $6.2M vs $9.1M YoY; system revenue $0.6M, recurring $5.6M.
Net loss $5.2M; prior-year net loss $1.2M included $2.2M PPP loan forgiveness.
Adjusted net loss (excl. stock comp) $2.5M; operating expenses $9.8M.
Cash $35.1M, no debt; expects year-end cash ~$32M; no additional financing needed.
Backlog over $12M supports 2022 revenue growth guidance; cautious on hospital construction timelines.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.